Browsing by Author "Bermejo, Begoña"
Now showing items 1-3 of 3
-
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
Quintela-Fandino, Miguel; Holgado, Esther; Manso, Luis; Morales, Serafin; Bermejo, Begoña; Colomer, Ramon; Cortés Castan, Javier (BMC, 2020-11-11) -
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
Pascual, Tomás; Antunes de Melo Oliveira, Ana Mafalda; Villagrasa, Patricia; Ortega Cebrian, Vanesa; Bermejo, Begoña; Nuciforo, Paolo Giovanni; Rubio Rodríguez, Isabel Teresa; Cortés Castan, Javier; Paré, Laia (Nature Research, 2021-11-25) -
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Garrido-Castro, Ana Christina; Barroso-Sousa, Romualdo; Guo, Hao; Ciruelos, Eva; Bermejo, Begoña; Serra Elizalde, Violeta; Rodon Ahnert, Jordi; Saura Manich, Cristina (BMC, 2020-11-02)